You are here: Industry Insights > SARS-CoV-2

News List

Developing a COVID-19 biosensor for faster diagnostics and environmental monitoring europeanpharmaceuticalreview
April 23, 2020
A team have developed a biosensor with high specificity and sensitivity for COVID-19 that could be used in hospitals, train stations or laboratories to detect SARS-CoV-2.
Starpharma’s SPL7013 shows significant activity against SARS-CoV-2 pharmaceutical-business-review
April 22, 2020
Starpharma announced that its proprietary VivaGel active, astodrimer sodium (SPL7013), has been shown in laboratory studies to have significant antiviral activity against the coronavirus that causes COVID-19 (coronavirus disease).
PDI’s Infection Prevention Products to be tested Against SARS-CoV-2 americanpharmaceuticalreview
April 21, 2020
PDI Healthcare is testing several of its disinfectant products for efficacy against SARS-CoV-2, the virus that causes COVID-19, for submission to the EPA for approval.
Quansys Biosciences Releases Multiplex Human Serological SARS-CoV-2 americanpharmaceuticalreview
April 20, 2020
Quansys Biosciences has released their SARS-CoV-2 Human IgG(4-plex) enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of SARS-CoV-2 reactive IgG class antibodies in human serum and plasma.
Soligenix Licenses BTG’s CoVaccine HT for SARS-CoV-2 contractpharma
April 17, 2020
Novel adjuvant has been shown to enhance both cell-mediated and antibody-mediated immunity.
Eurofins Genomics Launches SARS-CoV-2 Plasmid DNA Controls contractpharma
April 17, 2020
Can be used to detect the presence of SARS-CoV-2 virus and are intended for both R&D and diagnostic applications.
Ligandal Is Developing Potential Antidote And Vaccine To SARS-CoV-2 prnasia
April 14, 2020
Biological engineering company Ligandal, Inc. is applying its unique peptide-based delivery technologies to develop a prospective antidote and vaccine for SARS-CoV-2 (the novel coronavirus) to be formulated and developed in response to the worldwide pande
Luminex Receives Emergency Use Authorization for ARIES® SARS-CoV-2 Assay americanpharmaceuticalreview
April 10, 2020
Luminex announced the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its ARIES® SARS-CoV-2 Assay.
Recipharm’s Erdosteine to be Tested for COVID-19 Treatment contractpharma
April 09, 2020
Trial in Italy evaluating if Erdosteine improves respiratory symptoms and reduces the time to reach a negative test result for SARS-CoV-2.
Trial drug can significantly block early stages of COVID-19 in engineered human tissues worldpharmanews
April 07, 2020
An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page